Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery. [electronic resource]
Producer: 20060615Description: 261-8 p. digitalISSN:- 1478-3223
- Actins -- metabolism
- Animals
- Antiviral Agents -- therapeutic use
- Apoptosis -- drug effects
- Cholagogues and Choleretics -- therapeutic use
- Collagenases -- metabolism
- Drug Therapy, Combination
- Hydroxyproline -- metabolism
- In Situ Nick-End Labeling
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Kupffer Cells -- drug effects
- Liver Cirrhosis, Experimental -- drug therapy
- Male
- Matrix Metalloproteinase 13
- Polyethylene Glycols
- Rats
- Rats, Sprague-Dawley
- Recombinant Proteins
- Recovery of Function
- Tissue Inhibitor of Metalloproteinase-1 -- metabolism
- Ursodeoxycholic Acid -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.